Cardiovascular Drugs Market to 2030: APAC Leads Growth and Telehealth Helps Online Pharmacies Expand, Says Mordor Intelligence

Cardiovascular Drugs Market to 2030: APAC Leads Growth and Telehealth Helps Online Pharmacies Expand, Says Mordor Intelligence News provided by Mordor Intelligence Private Limited Oct 09, 2025, 10:01 ET Share this article Share to X Share this article Share to X HYDERABAD, India , Oct. 9, 2025 /PRNewswire/ -- According to Mordor Intelligence, cardiovascular drugs market is valued at USD 160.39 billion in 2025 and is projected to surpass USD 188.66 billion by 2030, growing at a CAGR of 3.30% during 2025-2030, supported by the global rise in cardiovascular disease (CVD) prevalence and ongoing innovation in therapeutic drug classes. Cardiovascular diseases remain the leading cause of death worldwide, driving continuous demand for effective treatment and preventive medications. Geographic Dynamics The Asia-Pacific region leads the cardiovascular drug market, driven by reforms and expanding healthcare infrastructure, which also boost opportunities for local companies and increase competition for international players. Japan's faster approval process supports the adoption of advanced therapies, including newer anticoagulants and metabolic treatments. North America continues to be a hotspot for innovation, with reimbursement systems favoring quick uptake of new therapies, though evolving pricing policies may influence how high-value drugs are launched. Primary Growth Drivers Therapeutic Convergence Driving Market Expansion New drug classes are reshaping treatment pathways. NOACs are rapidly replacing warfarin, while SGLT2 inhibitors and GLP-1 agonists extend beyond diabetes to heart-failure care and risk reduction, opening new market segments. Access Gains in High-Growth Regions Pricing reforms and expanded reimbursement in markets like China, India, and Brazil are boosting access to advanced cardiovascular drugs. Local manufacturing incentives and broader coverage are unlocking significant patient pools and fueling sustained market growth. Shifting Dynamics in Cardiovascular Care Cardiovascular disease is surging among older populations, with heart-failure prevalence climbing sharply. This ageing trend, seen globally, is driving demand for personalized therapies and combination treatments. Industry Segmentation Highlights The cardiovascular drugs market is segmented by drug class, disease indication, route of administration, distribution channel, and geography. Each segment plays a critical role in shaping the market's dynamics. By Drug Class Antihypertensives Anticoagulants Antiplatelet Agents Lipid-Lowering Drugs Heart-Failure Drugs Antiarrhythmics Pulmonary Hypertension Drugs By Disease Indication Hypertension Coronary Artery Disease Heart Failure Arrhythmia Dyslipidemia Venous Thrombo-Embolism By Route of Administration Oral Injectable / IV Transdermal & Others By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies By Geography North America United States Canada Mexico South America Brazil Argentina Rest of South America Europe Germany United Kingdom France Italy Spain Rest of Europe Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific Middle East & Africa GCC South Africa Rest of Middle East & Africa Learn more about the cardiovascular drugs market outlook at - https://www.mordorintelligence.com/industry-reports/cardiovascular-drugs-market?utm_source=prnewswire Strategic Players The cardiovascular drugs market is moderately competitive, with companies focusing on expanding their product portfolios, strategic alliances, and regulatory approvals. Market participants are also emphasizing biologics , biosimilars, and digital health integration to enhance patient monitoring and treatment outcomes. Comprehensive List of Market Players Pfizer Bristol Myers Squibb Novartis AstraZeneca Johnson & Johnson Merck & Co. Bayer Eli Lilly Boehringer Ingelheim Sanofi AbbVie Amgen Daiichi Sankyo Novo Nordisk GSK Takeda Abbott Laboratories Roche Servier Otsuka Pharmaceutical These firms continue to invest in clinical research and global partnerships to strengthen their foothold in the evolving cardiovascular therapeutics space. Check out related reports published by Mordor Intelligence: Anti Inflammatory Drugs Market : The Anti-inflammatory drugs market report Segments the Industry Into by Application (Arthritis, Chronic Obstructive Pulmonary Disease ), Drug Class (Anti-Inflammatory Biologics, Nsaids), Route of Administration (Oral, Parenteral), Sales Channel (Prescription, Over the Counter), and Geography (North America, Europe, Asia-Pacific). Anti-Obesity Drugs Market: The anti-obesity drugs market is projected to expand from USD 25.93 billion in 2025 to USD 100.97 billion by 2030, representing a CAGR of 31.24%. This growth is driven by the strong efficacy of GLP-1 receptor agonists, rising awareness of obesity as a chronic condition, and broader reimbursement coverage in developed markets. https://www.mordorintelligence.com/industry-reports/anti-obesity-drugs-market Omega-3 Prescription Drugs Market : The omega-3 prescription drugs Market report is Segmented by Product Type (EPA-Only, EPA + DHA Ethyl Esters, Indication (Severe Hypertriglyceridemia, Cardiovascular), Dosage Form (Soft-Gel Capsules 1g, Soft-Gel Capsules 0. 5g, Distribution Channel (Retail & Specialty Pharmacies), and Geography (North America, Europe). About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries, please contact: [email protected] https://www.mordorintelligence.com/contact-us Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg SOURCE Mordor Intelligence Private Limited 21 % more press release views with Request a Demo × Modal title